Sanyou Biopharmaceuticals and KangaBio set up strategic collaboration to speed up antibody drug growth and innovation

Shanghai, August 27, 2022 /PRNewswire/ — Most not too long ago, Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (Sanyou) and Shanghai KangaBio Co., Ltd. (KangaBio) has reached an antibody drug licensing settlement with respect to a proprietary monoclonal antibody drug developed by Sanyou, which grants KangaBio an unique license to use antibodies for analysis. Improvement, manufacturing and … Read more